Silicon Labs (SLAB) Stock May Be 48% Undervalued On Cash Flow
Silicon Laboratories has surged year to date, but the valuation signals are pulling in different directions, with an intrinsic value estimate suggesting the stock may be cheap while market based multiples lean the other way.
- Silicon Laboratories is up 65.6% year to date, so anyone looking at the stock today is dealing with a very different entry point than at the start of the year.
- Expectations for continued cash flow generation from its mixed signal and connectivity products can support the bull case, while any stretch in valuation multiples relative to current earnings power may limit how much investors are willing to pay.
- The stock scores 2 out of 6 on broader valuation checks, which means it currently leans expensive rather than reading as a clear bargain across multiple methods.
The issue now is whether Silicon Laboratories' strong year to date run already reflects most of the value that the intrinsic value estimate points to, or if there is still a margin of safety left at the current price.
Compare Silicon Laboratories' sharp year to date run with a curated list of other stocks that screen as potentially high quality and undervalued using our 45 high quality undervalued stocks.
Is Silicon Laboratories Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model used here estimates what Silicon Laboratories' future cash flows could be worth in today's dollars. Based on recent figures, the company has generated last twelve month free cash flow of about $3.6 million, and the model assumes that cash generation recovers and grows over time from this low base.
These long term cash flow projections lead to an estimated intrinsic value of about $421 per share. Compared with the current share price, the DCF output implies the stock trades at roughly a 48.1% discount to this estimate, which indicates the market is pricing Silicon Laboratories below the level supported by this cash flow model.
On these cash flow assumptions the stock currently appears undervalued relative to its DCF based intrinsic value estimate.
Our Discounted Cash Flow (DCF) analysis suggests Silicon Laboratories is undervalued by 48.1%. Track this in your watchlist or portfolio, or discover 45 more high quality undervalued stocks.
Is Silicon Laboratories Getting Expensive on Sales?
P/S is a helpful cross check for Silicon Laboratories because the company’s reported earnings are currently not a clean anchor for valuation.
Silicon Laboratories trades on a P/S of about 8.5x. That is above both the wider semiconductor industry average of around 6.5x and a peer group average of roughly 3.6x. On this measure, the stock is priced higher than many other revenue generating semiconductor companies.
The fair P/S ratio for Silicon Laboratories, which blends factors such as its growth profile, margins, size and risk, is about 7.3x. The current 8.5x level is therefore higher than what this framework suggests as reasonable, which indicates a premium price tag for the stock on sales alone.
On the P/S multiple Silicon Laboratories stock appears overvalued compared with both tailored fair value estimates and broader industry benchmarks.
See what the numbers say about this price — find out in our valuation breakdown.
The Silicon Laboratories Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Silicon Laboratories pick up where the mixed DCF and P/S signals leave off. They explain which potential paths for Silicon Laboratories' growth, margins and earnings would need to occur for the stock to be worth clearly more or clearly less than today's price. Each narrative links its figures to a specific view of how growth, profitability and risks could shift over time so you can revisit that view as new information arrives on the Community page.
Community views on Silicon Laboratories are divided between seeing a growth-focused IoT opportunity and concern that current expectations already incorporate a lot of good news.
Bull case: roughly fairly valued
"Rapid expansion of smart home, healthcare, and industrial IoT deployments including multiple large scale customer production ramps and a deep design win pipeline supports robust, multi year revenue growth as the number of connected devices in these sectors accelerates..."
Read the full Bull Case to see why Silicon Laboratories could be undervalued
Bear case: 9% overvalued
"If next generation products do not convert the current opportunity funnel into sustained, high volume programs, product mix could drift toward lower contribution parts and compress gross margin from recent 60% plus levels..."
Read the full Bear Case to see why Silicon Laboratories could be overvalued
Do you think there's more to the story for Silicon Laboratories? Head over to our Community to see what others are saying!
The Bottom Line
For Silicon Laboratories, the Discounted Cash Flow (DCF) intrinsic value estimate points to a meaningful discount, while sales based multiples suggest the stock is already priced at a premium to peers. That split reflects different emphasis, with the DCF leaning on future cash flow recovery and the multiples view anchored in current revenue and sentiment toward comparable semiconductor stocks. Broader valuation checks are weak, so the supportive DCF signal sits against a cautious composite read. The key question from here is whether Silicon Laboratories can translate its product opportunities into sustained, higher margin cash generation that makes the current premium multiples look justified rather than stretched.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com